Understanding Processes, Outcomes, and Contexts in Medication Adherence: The Medication Adherence Context and Outcomes (MACO) Framework

被引:11
|
作者
Ellis, Rebecca J. Bartlett [1 ,3 ]
Haase, Joan E. [1 ]
Ruppar, Todd M. [2 ]
机构
[1] Indiana Univ, Sch Nursing, Sci Nursing Care, Indianapolis, IN 46202 USA
[2] Rush Univ, Coll Nursing, Dept Adult Hlth & Gerontol Nursing, Chicago, IL USA
[3] Indiana Univ, Sch Nursing, Dept Sci Nursing Care, 600 Barnhill Dr,E423, Indianapolis, IN 46202 USA
来源
PATIENT PREFERENCE AND ADHERENCE | 2023年 / 17卷
基金
美国国家卫生研究院;
关键词
medication management; health behavior; implementation; ecological models; medication adherence; TRIALS;
D O I
10.2147/PPA.S387813
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Poor medication adherence is a significant problem, yet interventions to improve it have been largely ineffective. Existing ecological models indicate that adherence is multi-dimensional; however, they do not reflect understanding of context-specific processes and how they lead to adherence outcomes. A framework that reflects context-specific processes is important because it could be used to inform context-specific intervention delivery and measure associated adherence outcomes. The purpose of this paper is to describe the Medication Adherence Context and Outcomes (MACO) framework, which includes contexts (ie, clinics, pharmacies, and home) and context-specific processes (ie, shared decision-making, prescription filling strategies, home medication management) that lead to adherence outcomes (initiation, implementation, discontinuation, and persistence). The Medication and Adherence Contexts and Outcomes (MACO) framework was iteratively developed between 2015 and 2018 based on theory, practice, and research and combining patient experience journey mapping to chronologically describe the environmental contexts and actions (processes) that occur within the contexts and how they contribute to medication adherence as outcome. The three distinct yet interrelated contexts described in the MACO framework are 1) clinical encounters, 2) pharmacy encounters, and 3) day-to-day home management. Within these contexts are specific medication management actions that occur (processes) in order to produce adherencerelated outcomes (initiation, implementation, and discontinuation/persistence). The MACO framework distinguishes context-specific processes and outcomes. The MACO framework may be useful to understand at which point(s) along the continuum people experience problems with managing medications. This understanding is potentially useful for developing and delivering context-specific interventions that are based on processes that underlie nonadherence and selecting adherence measures appropriate for the contexts.
引用
收藏
页码:239 / 248
页数:10
相关论文
共 50 条
  • [41] ASSESSING THE VALUE OF LESS FREQUENT MEDICATION DOSING ON ADHERENCE AND OUTCOMES
    Veenstra, D. L.
    Alfonso, R.
    Best, J. H.
    Bruhn, D.
    Garrison, L. P.
    VALUE IN HEALTH, 2009, 12 (03) : A167 - A167
  • [42] Electronic monitoring feedback to improve medication adherence and clinical outcomes
    Van Heuckelum, M.
    van den Ende, E.
    Houterman, A.
    Heemskerk, C.
    van Dulmen, S.
    van den Bemt, B.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 558 - 558
  • [43] Medication alliance: Enhancing adherence and therapeutic outcomes for people with psychosis
    Deane, F.
    Byrne, M.
    AUSTRALIAN JOURNAL OF PSYCHOLOGY, 2006, 58 : 130 - 130
  • [44] Navigating Hazardous Conditions: Understanding HIV Medication Adherence in the Context of Depression
    Wendorf, Angela R.
    Mosack, Katie E.
    QUALITATIVE HEALTH RESEARCH, 2013, 23 (04) : 541 - 554
  • [45] Medication understanding, non-adherence, and clinical outcomes among adult kidney transplant recipients
    Patzer, Rachel E.
    Serper, Marina
    Reese, Peter P.
    Przytula, Kamila
    Koval, Rachel
    Ladner, Daniela P.
    Levitsky, Josh M.
    Abecassis, Michael M.
    Wolf, Michael S.
    CLINICAL TRANSPLANTATION, 2016, 30 (10) : 1294 - 1305
  • [46] Scope and Consistency of Adherence Related Outcomes in Randomized Controlled Trials of Interventions for Improving Medication Adherence
    Kelly, Ayano
    Sumpton, Daniel
    O'Sullivan, Clare
    Meara, Alexa
    Nieuwlaat, Robby
    Tugwell, Peter
    March, Lyn
    Tong, Allison
    Toupin-April, Karine
    Nantel, Francois
    Van den Bemt, B. J. F.
    De Vera, Mary
    Evans, Vicki
    Campbell, Willemina
    Wong, Peter
    Davey, Rebecca
    Beaton, Dorcas
    Suarez-Almazor, Maria
    Hassett, Geraldine
    Keen, Helen I.
    Dawson, Therese
    Crimston-Smith, Luke
    Tymms, Kathleen
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [47] ADHERENCE TO MEDICATION
    LUSCHER, TF
    VETTER, W
    JOURNAL OF HUMAN HYPERTENSION, 1990, 4 : 43 - 46
  • [48] Adherence to medication
    Krienke, R
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (18): : 1973 - 1973
  • [49] Medication adherence
    Howland, Robert H.
    PSYCHIATRIC ANNALS, 2008, 38 (05) : 323 - 326
  • [50] Medication adherence
    Howland, Robert H.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2007, 45 (09) : 15 - 19